Scott + Scott, LLC Updates GlaxoSmithKline -- Investors Have Until Monday, June 13, 2005, to File Lead Plaintiff Petitions COLCHESTER, Conn., June 9 /PRNewswire/ -- On behalf of client shareholders, Scott + Scott, LLC, filed a securities class action against GlaxoSmithKline PLC (NYSE:GSK) in May 2005. The complaint charges Glaxo and certain of its officers and directors with federal securities law violations (Securities Exchange Act of 1934). If you purchased Glaxo securities between February 21, 2001, and August 5, 2004 ("Class Period"), and sustained damages you may -- no later than June 13, 2005 -- move for lead plaintiff appointment to represent the investor class. During the Class Period, the action alleges, Glaxo's stock and ADR prices were artificially inflated while defendants concealed deficiencies with the Company's selective serotonin reuptake inhibitor ("SSRI") drug, Paxil, in treating adolescent depression. On August 5, 2004, The Wall Street Journal published an article that reported that a new FDA analysis confirmed the link between SSRIs (including Paxil) and suicidal tendencies in young people. Glaxo's stock and ADR prices plummetted from about $55 per share to $40 per share as the falsity of defendants' statements came to light. A lead plaintiff must meet certain requirements mandated by law and shareholders will only be proposed for this position upon direct consultation with the firm. Further information can be obtained from Scott + Scott at 800-404-7770 (east) or 800-332-2259 (west). Scott + Scott, LLC, a Connecticut-based law firm with offices in Ohio and California, has a national practice and reputation. Scott + Scott has dedicated itself to client communication and satisfaction. The firm is currently litigating major securities, antitrust and employee retirement plan cases throughout the United States and represents pension funds, charities, major corporations, foundations, individuals and other entities worldwide. Visit Scott + Scott's website ( http://www.scott-scott.com/ ) to learn more about the firm, its practice, attorneys and other cases. If you wish to discuss this action with an attorney or have any questions concerning this notice, your rights or any matter within our expertise, please contact attorney Amy K. Saba at 800-332-2259 (ext. 26) or by e-mail ( ). DATASOURCE: Scott + Scott, LLC CONTACT: Amy K. Saba, Scott + Scott, LLC, +1-800-332-2259, ext. 26, or Web site: http://www.scott-scott.com/

Copyright